CHARLES SCHWAB INVESTMENT MANAGEMENT INC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$1,424,000
-53.5%
294,035
+2.2%
0.00%
-50.0%
Q4 2019$3,060,000
+6.8%
287,844
+4.6%
0.00%0.0%
Q3 2019$2,866,000
+98.8%
275,281
+192.6%
0.00%
+100.0%
Q2 2019$1,442,000
+18.5%
94,081
-0.6%
0.00%0.0%
Q1 2019$1,217,000
+99.2%
94,677
+47.3%
0.00%
Q4 2018$611,000
-43.0%
64,291
-0.4%
0.00%
-100.0%
Q3 2018$1,072,000
+13.1%
64,555
+9.4%
0.00%0.0%
Q2 2018$948,000
+13.9%
59,025
+8.7%
0.00%0.0%
Q1 2018$832,000
+13.4%
54,325
+15.5%
0.00%0.0%
Q4 2017$734,000
+64.2%
47,025
+17.0%
0.00%
Q3 2017$447,000
+20.8%
40,2000.0%0.00%
Q2 2017$370,000
+7.6%
40,2000.0%0.00%
Q1 2017$344,000
+23.3%
40,200
+54.6%
0.00%
Q4 2016$279,000
-1.1%
26,0000.0%0.00%
Q3 2016$282,000
+59.3%
26,0000.0%0.00%
Q2 2016$177,000
+35.1%
26,000
-7.1%
0.00%
Q1 2016$131,000
-26.0%
28,0000.0%0.00%
Q4 2015$177,000
-28.6%
28,0000.0%0.00%
Q3 2015$248,000
-24.8%
28,0000.0%0.00%
Q2 2015$330,000
-18.7%
28,0000.0%0.00%
-100.0%
Q1 2015$406,000
+82.9%
28,000
+115.4%
0.00%
Q4 2014$222,000
+37.0%
13,0000.0%0.00%
Q3 2014$162,000
-15.2%
13,0000.0%0.00%
Q2 2014$191,000
-27.9%
13,0000.0%0.00%
Q1 2014$265,000
+3.9%
13,0000.0%0.00%
Q4 2013$255,000
-58.4%
13,0000.0%0.00%
-100.0%
Q3 2013$613,000
+88.0%
13,0000.0%0.00%0.0%
Q2 2013$326,00013,0000.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q1 2020.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders